Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-02-11

FDA Approved: CLINDESSE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for CLINDESSE (clindamycin phosphate) from Padagis Israel Pharmaceuticals Ltd, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLINDESSE (CLINDAMYCIN PHOSPHATE)

Snippet

SUPPL AP for CLINDESSE (CLINDAMYCIN PHOSPHATE)